Sign In
Buy INNMF
$0.0765
+0 (+0%)
At Close: Nov 17, 2025
Amplia Therapeutics Earnings Calls
Sep 30, 2025
(Upcoming)
| Release date | Nov 25, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 0% |
Jul 01, 2025
(Upcoming)
| Release date | Nov 25, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 0% |
Mar 31, 2025
| Release date | May 30, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
| Release date | May 30, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Amplia Therapeutics
Below you can see how INNMF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2024
| Release date | May 30, 2025 |
| Price on release | $0.0375 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 23, 2025 | $0.0324 |
| May 27, 2025 | $0.0324 |
| May 28, 2025 | $0.0375 |
| May 29, 2025 | $0.0375 |
| May 30, 2025 | $0.0375 |
| Jun 02, 2025 | $0.0375 |
| Jun 03, 2025 | $0.0390 |
| Jun 04, 2025 | $0.0390 |
| Jun 05, 2025 | $0.0375 |
| 4 days before | 15.74% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 15.74% |
Mar 31, 2025
| Release date | May 30, 2025 |
| Price on release | $0.0375 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 23, 2025 | $0.0324 |
| May 27, 2025 | $0.0324 |
| May 28, 2025 | $0.0375 |
| May 29, 2025 | $0.0375 |
| May 30, 2025 | $0.0375 |
| Jun 02, 2025 | $0.0375 |
| Jun 03, 2025 | $0.0390 |
| Jun 04, 2025 | $0.0390 |
| Jun 05, 2025 | $0.0375 |
| 4 days before | 15.74% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 15.74% |
Jul 01, 2025
(Upcoming)
| Release date | Nov 25, 2025 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $0.0765 |
| Nov 12, 2025 | $0.0765 |
| Nov 13, 2025 | $0.0765 |
| Nov 14, 2025 | $0.0765 |
| Nov 17, 2025 | $0.0765 |
Sep 30, 2025
(Upcoming)
| Release date | Nov 25, 2025 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $0.0765 |
| Nov 12, 2025 | $0.0765 |
| Nov 13, 2025 | $0.0765 |
| Nov 14, 2025 | $0.0765 |
| Nov 17, 2025 | $0.0765 |
Amplia Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for INNMF?
Amplia Therapeutics Ltd. (INNMF) has scheduled its earnings report for Nov 25, 2025 before the markets open.
What is the INNMF price-to-earnings (P/E) ratio?
INNMF P/E ratio as of Nov 17, 2025 (TTM) is -6.31.
What is the INNMF EPS forecast?
The forecasted EPS (Earnings Per Share) for Amplia Therapeutics Ltd. (INNMF) for the first fiscal quarter 2025 is $.
What are Amplia Therapeutics Ltd.'s retained earnings?
On its balance sheet, Amplia Therapeutics Ltd. reported retained earnings of $0 for the latest quarter ending Mar 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
